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Myopia is a refractive error which affects every age group person around 
the world. Specially in modern age when the use of mobile screen and 
computer is increased so much, this error has become horrible. The 
symptoms of myopia closely resembles with the disease Timir. It involves 
Pratham and Dwitiya patala of Netra. In the present study, 35 clinically 
diagnosed patients of Timira/Myopia were selected and randomly 
divided into two groups (Group-A-18 patients, Group-B-17patients) out 
of these, 30 patients completed the trial. Patients of group A were 
administrated Timirhar Lauha orally. While patients of group B were 
topically administrated Baladi Ghrita for Tarpana and Timirhar Lauha 
orally. The study shows that Timirhar Lauha (systemic drug) alone was 
effective in all symptoms of Timira /Simple Myopia but combination of 
the drug Timirhar Lauha (systemic drug) with Baladi Ghrita (Tarpana/ 
topical application) had much greater potential to ameliorate the 
symptoms of Timira /Simple Myopia. 
 
INTRODUCTION
Timira is the Drishtigata Rog explained by 
all the Acharyas. Timira is a disease, which starts 
with simple visual disturbance (Avyakta Darshana) 
but if unattended it may lead to ends in complete 
loss of vision (Linganasha). Due to this reason all 
the Acharyas have paid special attention to this 
disease. The clinical features of Timira (first 
Patalashrita- Avyakta Darshana- indistinct distance 
vision and second Patalashrita- Vihwala Darshana- 
blurred vision) can be correlated symptomatically 
with refractive errors.  
Myopia or short-sightedness is type of 
refractive error in which parallel rays of light 
coming from infinity are focused in front of the 
retina when accommodation is at rest[1]. Myopia is a 
highly significant problem not only because of its 
high prevalence, but also because it can contribute 
to visual morbidity and increase the risk for vision-
threatening conditions (e.g. retinal breaks and 
detachment, glaucoma etc.). 
 
In Ayurveda, various treatment 
formulations are advocated for Timira Roga for 
enhancement of vision. Here Timirhar Lauha (Ref. 
Rasendrasara samgrah[2]) was selected for present 
study along with local therapy of Akshi Tarpana 
with Baladi ghrita (Ref.Yogratnakar[3]). 
As the disease Timira (Myopia) is 
degenerative in nature, the Chakshushya, Rasayana 
and Tridosha mitigating action might be helpful in 
such type of disorders. Majority of Rasayana drugs 
work on multiple areas and helps in achievement of 
Vyadhikshamatwa through its Dipana, Pachana, 
Medhya and non specific immune booster 
properties. Chakshushya term indicate for 
regeneration of eye sight. Ghrita is one among the 
best Rasayana drug and Triphala (which is main 
content of both selected drug) is one among the 
best Chakshushya drug. Thus a drug having both 
Chakshushya and Rasayana properties might be 
helpful for treating the disease Timira (myopia). 
According to Charaka, Ghrita improves Dhatus and 
is overall booster for Ojas[4].  
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Therefore, a clinical study was planned to 
study the efficacy of Timirhar Lauha orally and 
Baladi ghrita Tarpana for evaluating the efficacy of 
above therapies in reduction of dioptric power and 
visual improvement.  
The researches in Ayurveda are being 
carried out in different institutions all over the 
India with special attention to Timira and also to 
myopia. The present study is a step forward in that 
direction to find out the remedial measure for this 
problem with the topic entitled ‘A clinical study on 
the efficacy of Timirhar Lauha and Baladi Ghrita 
Tarpana in the management of Timira with special 
reference to Myopia’.  
 This clinical trial is interventional, 
randomized study and approved by Institutional 
Ethical committee NIA, Jaipur with letter number 
ICE/ACA/2015/88. 
MATERIALS AND METHODS  
Patients Selection  
Patients attending the O.P.D. & I.P.D. of P.G. 
Department of Shalakya Tantra, NIA, Hospital, 
Jaipur, Rajasthan, with signs and symptoms of 
myopia/Timira.  
35 patients of myopia, who attended O.P.D./ 
I.P.D. during this period were selected for present 
study.  
Inclusion Criteria  
1. Patients presenting with signs and symptoms of 
Timira, described as per Ayurvedic and modern 
science. 
2. Patients diagnosed with simple myopia were 
selected for the trial. 
Exclusion Criteria 
1. Patients not willing for the trial were excluded. 
2. Patients having any other ocular pathology, e.g., 
cataract, corneal opacity, iridocyclitis, retinal 
disease etc. were excluded.  
3. Patients suffering from systemic diseases. 
4.  Patients aged below 08 years and above 40 
years. 
5. Patients having a dioptre power more 
than−6.00 dioptre (Pathological myopia) were 
also excluded.  
Grouping of Patients 
In the present study 35 clinically diagnosed 
patients of Timira/Myopia were selected and 
randomly divided into two groups (Group-A-18 
patients, Group-B-17patients) out of these 35 
patients 30 patients completed the trial. 
Group A: 18 patients of Timira/Myopia were 
advised Timirhar Lauha orally. Group B: 17 
patients of Timira/Myopia were advised Baladi 
Ghrita for Tarpana and Timirhar Lauha orally. All 
the cases were examined initially in O.P.D. and were 
selected for study on the basis of clinical 
presentation and diagnostic criteria.  
Laboratory Investigations 
Hb gm%, TLC, DLC, ESR, RBS and Serum Cholesterol 
were advised to all the patients to rule out any 
sever pathology and to note the changes, if any. 
Drug Schedule  
Timirhar Lauha orally 
Dose: 500mg once a day with honey. 
Mode: oral 
Duration: 30 days  
Follow up: were done once in 15 days for a period 
of 45 days. 
Baladi Ghrita for Tarpana 
Poorva Karma 
 Purification of body by Avipathikara churana.  
 Snehana with Dashmoola taila followed by 
Swedana up to Samyak Swinna Lakshana Nasya 
with 6-6 drops of Anu taila for 3 days 
 Kavala Dharana with warm saline water. 
 Pradhana Karma  
 Mild fomentation with a cotton soaked in 
lukewarm water  
 Tarpana with Baladi ghrita after 3 days of Nasya 
Dose: Q. S. 
Mode: Tarpana 
Tarpana kala/ Aushadh dharan kal 
1000 Vak Matra (30 minutes approx.) 
Duration: 3 sittings of 5 days Tarpana each with 
interval of 5 days between the sittings.  
Follow up: were done once in 15 days for a period 
of 45 days after completion of trial. 
Criteria of Assessment 
Subjective 
The patients were subjectively assessed 
based on the symptoms– Avyakta Darshana 
(indistinct distant vision), Vihwala Darshana 
(blurred vision), Dwidha Darshana/ (Diplopia), 
Shirobhitapa (headache), Netrasrava (watering), 
Netrayasa (eye strain), and Netradaha (burning 
sensation) – by adopting the scoring pattern. 
Objective 
(1) Visual Acuity/LogMAR Value  
(2) Autorefractometry/Retinoscopy  
(3) Ophthalmoscopy 
(4) A scan 
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Grading 
Awyakta Darshna (Indistinct distance vision) 
0- No feeling of blurring of the vision 
1- Occasional blurring of the vision 
2-Routine blurring which affected routine work 
3- Regular blurring disturbing routine work 
4- Complete darkness before the eyes 
Vihwala Darshna/ (blurred vision)/ Makshikadi 
Abhuta Dravya Darshan (Floaters) 
 Visualization of non existing objects like flies, gnats, 
hairs, webs, circles, flags, mirage and ear rings. 
0- No such problem 
1- Occasional visualization of any such objects 
2- Irregular visualization of two to four kinds of the 
above mentioned objects 
3- Regular visualization of two to four kinds of the 
above mentioned objects 
4- Regular visualization of more than four kinds of 
the above mentioned objects 
Dwidha Darshana (Diplopia) 
0 - No diplopia 
1 - Occasional diplopia 
2 - Regular diplopia without disturbing routine 
work 
3 - Regular diplopia disturbing day-to-day work 
Shirobhitapa (Headache) - Scored on the 
frequency of attacks 
0 - No headache 
1 - Occasional headache 
2 - Irregular attacks of frequent headache 
3 - Regular attacks of Headache 
Netrayasa (Eye Strain) - It was recorded on the 
basis of minimum time taken to produce eye strain 
after near work 
0 - More than 6 hrs of near work 
1 - After 4- 6 hrs of near work 
2 - After 2- 4 hrs of near work 
3 - Before 2 hrs of near work.  
Netrasrava (Watering) 
0 – No Watering 
1 – Occasional Watering 
2–Regular Watering without disturbing routine 
work 
3 – Regular Watering disturbing routine work 
Netradaha (Burning sensation) 
0-No Burning sensation 
1-Occasional Burning sensation  
2-Regular Burning sensation without disturbing 
routine work 
3-Regular Burning sensation disturbing routine 
work 
Statistical Analysis 
Various observations made and results 
obtained were computed statistically using Student 
t – test, Wilcoxon matched pairs signed ranks test 
and Mann Whitney test on graph Pad Instat 3 
software. 
The results obtained were considered 
Extremely Significant for p value <0.0001, Very 
significant for <0.001, significant for p value <0.01 
and insignificant for p value >0.05. 
Observation 
In present study 45.17% patients were 
found in the age group of 17-24 years. According to 
a survey in Taiwan population there was an 
increasing prevalence of myopia with age, from 4 
percent at age of 6 years to 40 percent at age of 12 
years further, more than 70 percent at the age of 15 
years, and more than 75 percent at age 18 years[5]. 
Only 2 patients were found in age group of 33-40 
years, some studies showed the decreasing 
prevalence of myopia with age (between the ages of 
43 and 84 years)[6]. 
The percentage of female was 57.14% 
whereas male was 42.86%. Thus studies showed 
that the prevalence rate was higher in females than 
males[7,8,9].  
In present study, among 35 patients, 
77.14% patients were Hindu, 14.28% others and 
8.57% patients were Muslims. This might have 
occurred due to the dominance of the Hindu 
community in this region. However, this data is not 
suggestive of any confirmed finding regarding the 
disease.  
Majority of the patients were unmarried 
(80%). This only signifies that most of the patients 
belonged to younger age group and were students.  
Majority of patients 54.28% were graduates and 
14.28% were post graduates. Duration and level of 
education is highly correlated with time spent on 
reading and writing. Educational level and 
intelligence are strongly related to amount of close 
up work and are probably not independent risk 
factors but surrogates for close up work[10,11,12].  
In occupation wise distribution of patients, 
out of 35 patients majority of the patients i.e. 
91.42% were students, it may be due to the fact that 
students had a higher prevalence of myopia[13]. 
In this study most of the patient belonged to 
upper middle (54.28%) and middle economical 
class (37.14%). It reflects that the area of study is 
predominantly represented by upper middle 
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economic class. This may be due to maximum 
subjects spending more time on computer and 
gadgets. 
Maximum numbers of patients were on 
Vegetarian diet (77.14%). This is because maximum 
patients were from Hindu community and they 
used to take vegetarian diet. So we cannot say 
clearly that the vegetarian diet may promote the 
development of the disease. 
Majority of patients were having good 
appetite 54.28%. Majority of patients (85.71%) 
were having regular bowels. Maximum number of 
patients, 94.28% were having normal micturition. 
Maximum number of patients 68.57% were of Vata 
Pittaja Prakriti.  
Maximum no. of patients showed 
Madhyama Sara (77.14%), Samhanana (74.28%), 
Pramana (82.85%), Satva (71.42%), Satmaya 
(74.28%). No specific relation can be established 
between them and the disease myopia from this 
small number of data. 
Maximum no. of patients showed 
Madhyama Abhyavaharana and Jarana Shakti both 
were 74.28%. 77.14% patients were having 
Madhyama Vyayama Shakti. 
Maximum patients 94.28% were of Bala 
Vaya (up to 30 years according to Acharya 
Charaka). 
 In the present study 91.42% patients were 
having addiction to tea while 8.58% patients were 
having no addiction. This indicates general trend of 
drinking tea as beverage. 
Maximum number of patients spent 5-6 
hours in front of Visual Display Screen (51.42%) 
followed by 37.14% patients spent 3-4 hours in 
front of visual Display. In Ayurveda, Atiyoga or 
Sookshmanireekshnat is a main etiological factor for 
eye diseases. According to modern science, close up 
work encompasses tasks of high accommodative 
demand, such as reading, writing, computer work, 
close television viewing, play video games and use 
of mobile phone. There are several theories which 
attribute close up work to the increase in axial 
length that causes myopia. One of the most widely 
held theories is the accommodation theory, wherein 
there is an increase in pressure in the posterior part 
of the eye during accommodation which is poorly 
resisted by the sclera, resulting in increased ocular 
length[14].  
All the patients, 100% were from urban 
areas. According to previous studies, it was 
observed that in urban areas myopia rates are 
higher than in rural areas[15,16].  
Maximum number of patients, (82.85%) had 
sound sleep. Maximum numbers of patients, 
57.14% were having positive family history.  
Parental myopia is considered as a marker for both 
genes and a shared family environmental exposure. 
Myopic parents are more likely to create 
myopigenic environments such as more intensive 
education or less time spent outdoors.[17,18] 
Table 1: Incidence of Positive Symptoms in 35 Patients 
Parameters Group A Group B Total Percentage 
Avyakta Rupa Darshan/ Duram na pashyate 
(Indistinct distance vision) 
18 17 35 100% 
Vihwala Darshana (Blurred vision) and Makshikadi 
abhuta dravya darshan (Floaters) 
07 12 19 54.28% 
Dwidha/ Bahuvidha darshan (Diplopia/ Polypia) 0 0 0 0% 
Shirobhitapa (Headache) 13 13 26 74.28% 
Netrayasa (Eye strain) 16 15 31 88.57% 
Netrasrava (Watering) 7 5 12 34.28% 
Netradaha (Burning sensation) 9 13 22 62.85% 
RESULTS AND DISCUSSION 
Effect of Therapy on Subjective Parameters  
Relief in the symptom of Avyakta Darshana 
was observed 27.71% in Group A (p=0.0012), and 
68.66% in Group B (p<0.0001), there was 
extremely significant difference between BT and AT 
scoring of two groups, Group B showed 40.95% 
more relief than Group A. which indicated that the 
combined effect of Tarpana and Timirhar Lauha is 
better than only Timirhar Lauha on visual feeling. 
Relief in the symptom of Vihwala Darshana/ 
Makshikadi Abhuta Dravya Darshana was 15% in 
Group A (p=0.5000), and 64.51% in Group B 
(p<0.0001) and these values were statistically not 
significant in Group A and extremely significant in 
Group B. So there was extremely significant 
(P<0.0001) difference found between BT and AT 
AYUSHDHARA, 2020;7(Suppl 1):56-63 
 AYUSHDHARA | September - October 2020 | Vol 7 | Suppl 1  60 
scoring of two groups, even though Group B showed 
49.51% better relief than Group A. Relief in the 
symptom of Shiroabhitapa was observed 56.15% in 
Group A (p=0.0020), and 86% in Group B 
(p=0.0005) and these values were statistically very 
significant in group A and extremely significant in 
group B. Relief in the symptom of Netrayasa was 
26.19% in Group A (p=0.0020), and 88.49% in 
Group B (p<0.0001) and these values were 
statistically very significant in Group A and 
extremely significant in Group B. in the symptom of 
Netrasrava was 33.33% in Group A (p=0.0020), and 
82.50% in Group B (p=0.0020) these values were 
statistically significant in Group A and very 
significant in Group B. Relief in the symptom of 
Netradaha was 31.50% in Group A (p=0.0313), and 
78.30% in Group B (p<0.0001) these values were 
statistically significant in Group A and extremely 
significant in Group B.  
Table 2: Comparison of Relief in Terms of Percentage in Two Groups 
S.No. Symptoms Percent Relief 
Group A Group B 
1 Avyakta Darshana 27.71 68.66 
2 Vihwala Darshana/ Makshikadi abhuta 
dravya darshana 
15.00 64.51 
3 Shiroabhitapa 56.15 86.00 
4 Netrayasa 26.19 88.49 
5 Netrasarva 33.33 82.50 
6 Netradaha 31.50 78.30 
7 LogMAR Value 12.28 23.17 
Average percentage of relief 28.88 70.26 
Table 3: Intergroup Comparison of Subjective Parameters of Myopia /Timira (Mann Whitney test) 
S.No. Symptoms 
Mean S.D. S.E. 
U P Results 
GA GB GA GB GA GB 
1 Avyakta Darshana 0.56 1.6 0.56 0.62 0.10 0.11 774 <0.0001 ES 
2 Vihwala Darshana/ 
Makshikadi abhuta 
dravya darshana  
0.06 0.60 0.25 0.49 0.04 0.09 210 <0.0001 ES 
3 Netrayasa 0.30 1.00 0.46 0.52 0.08 0.09 723 <0.0001 ES 
4 Shiroabhitapa 0.73 0.86 0.59 0.51 0.15 0.13 126.50 0.4988 NS 
5 Netrasrava 0.26 0.33 0.44 0.47 0.08 0.08 480 0.5827 NS 
6 Netradaha 0.20 0.83 0.48 0.53 0.08 0.09 713 <0.0001 ES 
On the basis of above results we can say that 
the improvements in the subjective feeling are 
better in Group B. Therefore we infer that the drug 
Timirhar Lauha with Baladi Ghrit Tarpan is very 
effective for the improvement of subjective feeling 
like Avyakta Darshana, Vihwala Darshana/ 
Makshikadi Abhuta Dravya Darshana, Shiroabhitapa, 
Netrayasa, Netrasrava and Netradaha.  
Effect of Therapy on Objective Parameters 
Statistically extremely significant relief 
were found in LogMAR value of 12.28% in Group A 
(p<0.0001), and 23.17% in Group B (p<0.0001). 
However there was extremely significant difference 
between BT and AT scoring of two groups 
(p<0.0001) with Group B showing 10.89% better 
relief than Group A. In this trial insignificant result 
was observed in K1 and K2 in intra group 
comparison before treatment and after treatment. 
In this study insignificant results were observed in 
A Scan in intra group comparison before treatment 
and after treatment. Effect on dioptric power/ 
clinical refraction was found to be significant result 
(p=0.0117) in group A (3.70%), while it was 
extremely significantly (p<0.0001) in group B 
(19.53%). However there was Not significant 
difference between two groups (p=0.2741) 
statistically with Group B showing 15.83% more 
relief than Group A. 
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Table 4: Intergroup Comparison on Objective Parameter of Timira (Student unpaired ‘t’ test) 
S.No. Objective parameter Mean S.D. S.E. t P Resul
t GA GB GA GB GA GB 
1 LogMAR Value  0.07 0.19 0.09 0.12 0.01 0.02 4.22 <0.001 ES 
2 K1  -0.20 0.21 0.29 0.28 0.05 0.05 0.71 0.9436 NS 
3 K2  -0.14 0.23 0.29 0.28 0.05 0.05 1.28 0.2057 NS 
4 A Scan  0.13 0.17 0.14 0.12 0.02 0.02 1.15 0.2514 NS 
5 Dioptric Power/ 
Clinical Refraction  
0.02 0.01 0.12 0.48 0.02 0.08 1.10 02741 NS 
Effect of Therapy on Laboratory Parameters 
In this trial, insignificant results were observed in Hb, TLC, Neutrophils, Lymphocytes, Eosinophils, 
Monocytes, ESR, Random Blood Sugar and Serum Cholesterol in intra group and inter group comparison 
Table 5: Intergroup Comparison of Laboratory Parameter of Timira (Student unpaired ‘t’ test) 
S.No. Laboratory 
parameter 
Mean S.D. S.E. t P Result 
GA GB GA GB GA GB 
1 HB 0.56 0.56 0.55 0.80 0.14 0.20 2.15 >.9999 NS 
2 TLC 1080.01 1393.31 1191.8 1086.6 307.71 280.56 0.75 0.4581 NS 
3 Neutrophils 8.33 10.06 6.33 7.58 1.63 1.95 0.67 0.5024 NS 
4 Lymphocytes 4.60 7.93 7.92 5.78 2.04 1.49 1.315 0.1990 NS 
5 Eosinophils 2.80 2.86 4.14 4.50 1.07 1.16 0.04 0.9666 NS 
6 Monocytes 2.06 2.26 2.31 1.90 0.59 0.49 0.258 0.7980 NS 
7 ESR 5.33 3.86 4.25 4.82 1.09 1.24 0.88 .3846 NS 
8 RBS 13.00 11.13 16.98 14.80 4.38 3.82 0.32 0.7507 NS 
9 Serum 
cholesterol 
21.46 20.46 19.51 14.74 5.04 3.80 0.15 0.8753 NS 
Probable mode of action of trial drug 
Contents of Timirhar lauha- Triphala, Loha 
bhasma, Yasthimadhu, Padmakamal. 
Anupan- Madhu 
Contents of Baladi Ghrita- Bala, Triphala, kakoli, 
(Ashwagandha), Shatavari, Saileyaka, Sita, Go-ghrita 
Contents of both formulations have Chakshushya, 
Rasayana and Tridoshshamak properties. Triphala, 
Yasthimadhu, Loha bhasma, Ashwagandha and 
Shatavari are well established Chakshushya and 
Rasayana drugs. Bala is Balya and best for 
Vatashaman. Padmakamal and Saileyaka are 
Pittashamak they reduce Daha (burning sensation) 
which is a very important associated symptom in 
Timir/ Myopia. Goghrita is also having above said 
properties. Ghrita due to its Sansakaranuvartana 
quality easily imbibes the properties of other drugs 
processed with it without leaving its own 
properties. According to Bhavprakash Madhu is best 
Anupan and have Vata Pittahara, Graahi, Lekhana, 
Chakshushya, Saukumaryakara, Dipana, 
Srotovishodhana, Yogavahi, Medhakara, Vrishya, 
Rochana, Prasadajanaka properties. Thus Timir 
which is a Vatapitta dominating Tridoshaja Vyadhi 
and considering its associated symptoms like 
Netradaha (Burning sensation), Shirobhitapa 
(Headache), Netrayasa (Eye strain), Netrasrava 
(Watering) etc. Timirhar Lauha and Baladi Ghrita 
are selected for the study. After analyzing the 
content of both formulations we can say that they 
are helpful to mitigating Vatapitta and may cure the 
associated symptoms. 
Probable Mode of Action of Tarpana 
The disease Timira is Vata Pradhana 
Tridoshaja vyadhi so compound drug employed 
should also have Tridoshaghna qualities that can 
counteract vitiated Doshas to disintegrate the 
pathology of the disease. In eye diseases, Acharyas 
gave special emphasis to Kapha Dosha hence Kapha 
should be controlled first, for this purpose Nasya is 
the best treatment and after that Tarpaņa should be 
advised with medicated Ghrita for Vata and Pitta 
Shamana[19]. In the description of Drishti, Sushruta 
has mentioned that Sheeta Dravyas are Satmya for 
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Drishti. Ghrita is also Sheeta Virya, hence the eye 
being the site of Alochaka Pitta can be effectively 
managed by topical administration of Ghee in 
Tarpana. Ghrita contains properties like Balya, 
Brimhaņa and Rasayana, so it gives strength to the 
overall tissues of the eyeball as well as to the 
nervous tissues. According to Charaka, Timira is a 
Vata Nanatmaja Vyadhi, so mainly Vata aggravating 
causative factors are responsible for Timira. Sneha 
is the best drug to pacify the vitiated Vata. Acharya 
Charaka considered Tarpana as one of the Sneha-
Pravicaraņa. Tarpaņa provides Vatasamaka effect 
and nourishment to the eyes thus improves visual 
acuity. Among all Kriyakalpas, Netra Tarpana is the 
foremost procedure for eye disorders. It acts as 
both preventive and curative therapy for 
maintaining normal healthy condition of eyes. All 
the ingredients of Baladi Ghrita are having 
Chakshushya and Rasayana properties; therefore 
Baladi Ghrita was selected for Tarpana. 
CONCLUSION 
 Features related to visual disturbances have 
been described under Drishtigata Rogas. Timira 
comes under this group of diseases. Timira is a 
disease when the vitiated Doshas are situated in the 
first and second Patala. On the basis of similarities 
in symptoms, involvement of anatomical structures, 
aetiology and prognosis, Timira can be correlated 
with the refractive errors in general including 
myopia. The modern counterpart has made 
wonderful and remarkable progress in the field of 
ophthalmology but no satisfactory and universally 
accepted treatment for myopia is available. 
Ayurvedic text enumerates number of treatment 
modalities for the treatment of eye diseases, 
including both localized and systemic measures. 
 Topical applications play essential role, may 
be due to the limitation of systemic formulations to 
reach the target organ due to blood ocular barriers. 
The study shows that Timirhar Lauha 
(systemic drug) alone was effective in alleviating 
symptoms of Timira/Simple Myopia but 
combination of the drug Timirhar Lauha (systemic 
drug) with Baladi Ghrita (Tarpana/topical 
application) had much greater potential to 
ameliorate the symptoms of Timira /Simple Myopia. 
Thus study showed that local therapy combined 
with systemic therapy give better result in Timira/ 
Simple Myopia. No adverse effects were seen in 
both the groups. 
However, the results of this study and the 
conclusion drawn there upon need to be further 
clarified by conducting a large scale placebo 
controlled clinical trial. 
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